AIM IMMUNOTECH INC. Derivative, Gain on Derivative
AIM IMMUNOTECH INC. (AIM) reported Derivative, Gain on Derivative of $14.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainOnDerivative · last filed 2015-03-19
- AIM IMMUNOTECH INC. derivative, gain on derivative for the quarter ending 2014-12-31 was $13.00K, a 75.00% decline year-over-year.
- AIM IMMUNOTECH INC. derivative, gain on derivative for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. derivative, gain on derivative for the quarter ending 2014-06-30 was $1.00K, a 99.02% decline year-over-year.
- AIM IMMUNOTECH INC. derivative, gain on derivative for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. derivative, gain on derivative for fiscal 2014 was $14.00K, a 95.02% decline from fiscal 2013.
- AIM IMMUNOTECH INC. derivative, gain on derivative for fiscal 2013 was $281.00K, a 230.59% increase from fiscal 2012.
- AIM IMMUNOTECH INC. derivative, gain on derivative for fiscal 2012 was $85.00K, a 96.49% decline from fiscal 2011.
- AIM IMMUNOTECH INC. derivative, gain on derivative for fiscal 2011 was $2.42M, a 175.88% increase from fiscal 2010.
| Period end | Derivative, Gain on Derivative 3 month | Derivative, Gain on Derivative 6 month | Derivative, Gain on Derivative 9 month | Derivative, Gain on Derivative 12 month |
|---|---|---|---|---|
| 2014-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $13.00K derived: sum of 2 quarters · filed 2015-03-19 | $14.00K derived: sum of 3 quarters · filed 2015-03-19 | $14.00K 10-K · filed 2015-03-19 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 | $1.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.00K 10-Q · filed 2014-11-07 | $53.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $1.00K 10-Q · filed 2014-08-08 | $1.00K 10-Q · filed 2014-08-08 | $53.00K derived: sum of 3 quarters · filed 2014-08-08 | $91.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $52.00K derived: sum of 2 quarters · filed 2014-05-09 | $90.00K derived: sum of 3 quarters · filed 2014-11-07 | $192.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | $52.00K 10-K · filed 2014-03-14 | $90.00K derived: sum of 2 quarters · filed 2014-11-07 | $192.00K derived: sum of 3 quarters · filed 2014-11-07 | $281.00K 10-K · filed 2015-03-19 |
| 2013-09-30 | $38.00K 10-Q · filed 2014-11-07 | $140.00K derived: sum of 2 quarters · filed 2014-11-07 | $229.00K 10-Q · filed 2014-11-07 | $2.05M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $102.00K 10-Q · filed 2014-08-08 | $191.00K 10-Q · filed 2014-08-08 | $2.01M derived: sum of 3 quarters · filed 2014-08-08 | $40.00K derived: sum of 4 quarters · filed 2014-08-08 |
| 2013-03-31 | $89.00K 10-Q · filed 2014-05-09 | $1.91M derived: sum of 2 quarters · filed 2014-05-09 | -$62.00K derived: sum of 3 quarters · filed 2014-05-09 | $325.00K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $1.82M 10-K · filed 2014-03-14 | -$151.00K derived: sum of 2 quarters · filed 2014-03-14 | $236.00K derived: sum of 3 quarters · filed 2014-03-14 | $85.00K 10-K · filed 2015-03-19 |
| 2012-09-30 | -$1.97M 10-K · filed 2014-03-14 | -$1.58M derived: sum of 2 quarters · filed 2014-03-14 | -$1.73M 10-Q · filed 2013-11-08 | -$865.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $387.00K 10-K · filed 2014-03-14 | $236.00K 10-Q · filed 2013-08-09 | $1.10M derived: sum of 3 quarters · filed 2014-03-14 | $1.72M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$151.00K 10-K · filed 2014-03-14 | $716.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.33M derived: sum of 3 quarters · filed 2014-03-14 | $1.97M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $867.00K 10-K · filed 2013-03-18 | $1.48M derived: sum of 2 quarters · filed 2013-03-18 | $2.12M derived: sum of 3 quarters · filed 2013-03-18 | $2.42M 10-K · filed 2014-03-14 |
| 2011-09-30 | $614.00K 10-K · filed 2013-03-18 | $1.26M derived: sum of 2 quarters · filed 2013-03-18 | $1.56M 10-Q · filed 2012-11-02 | $2.10M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $643.00K 10-K · filed 2013-03-18 | $944.00K 10-Q · filed 2012-08-08 | $1.48M derived: sum of 3 quarters · filed 2013-03-18 | $899.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $301.00K 10-K · filed 2013-03-18 | $840.00K derived: sum of 2 quarters · filed 2013-03-18 | $256.00K derived: sum of 3 quarters · filed 2013-03-18 | $2.52M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $539.00K 10-K · filed 2013-03-18 | -$45.00K derived: sum of 2 quarters · filed 2013-03-18 | $2.21M derived: sum of 3 quarters · filed 2013-03-18 | $879.00K 10-K · filed 2013-03-18 |
| 2010-09-30 | -$584.00K 10-K · filed 2013-03-18 | $1.68M derived: sum of 2 quarters · filed 2013-03-18 | $341.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $2.26M 10-K · filed 2013-03-18 | $924.00K 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | -$1.34M 10-K · filed 2013-03-18 | |||
| 2009-12-31 | $6.26M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |